ANRO4:03 PMAlto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlightsaltoneuroscience.com
ANRO7:47 AMAlto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stockaltoneuroscience.com